Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Mitsubishi Tanabe Pharma Corp    4508   JP3469000008

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Manufactures and distributes pharmaceuticals, pet products and medicines

Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products.

Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera.

It operates through the following geographical segments: Japan, Europe, Asia, North America, and Others.

The company was founded in 1678 and is headquartered in Osaka, Japan.
Sales per Businesses
20132014Delta
JPY (in Million)%JPY (in Million)%
Medical Supply419,179100%---
Pharmaceuticals--412,675100%-
Sales per Regions
20132014Delta
JPY (in Million)%JPY (in Million)%
Japan371,44488.6%353,30085.6% -5.14%
Europe26,4926.3%37,3489.1% +29.07%
Asia16,5914%15,9773.9% -3.84%
North America3,9400.9%5,6271.4% +29.98%
Other712.000.2%423.000.1% -68.32%
Managers
NameAgeSinceTitle
Masayuki Mitsuka, PhD612007President & Representative Director
Michihiro Tsuchiya, PhD681976Chairman
Kuniyoshi Wada--Managing Executive Officer & Head-Operations
Eizou Tabaru--Manager-Finance & Investor Relations Contact
Minoru Muramatsu--Head-Information Systems, Public Relations & Legal
Kenkichi Kosakai622007Director
Kouji Nakamura--Director
Yoshiaki Ishizaki--Director & Chief Compliance Officer
Takashi Kobayashi601980Director & Managing Executive Officer
Shigehiko Hattori742011Independent Director
Shareholders
NameShares%
Mitsubishi Chemical Holdings Corp. 316,320,000 56.3%
Nippon Life Insurance Co. 12,065,000 2.15%
Mitsubishi UFJ Financial Group, Inc. 9,372,113 1.67%
Tokio Marine Holdings, Inc. 4,095,900 0.73%
Nipro Corp. 3,821,700 0.68%
BlackRock Fund Advisors 3,579,200 0.64%
The Vanguard Group, Inc. 3,338,312 0.59%
Första AP-fonden 2,877,600 0.51%
Wellington Management Co. LLP 2,734,400 0.49%
Norges Bank Investment Management 2,720,679 0.48%
Holdings
NameShares%Valuation
SUZUKEN CO., LTD. (9987) 1,548,1921.50%48,579,107 USD
Alfresa Holdings Corporation (2784) 2,225,8120.95%33,423,461 USD
Medipal Holdings Corp (7459) 2,121,9360.87%29,097,493 USD
VITAL KSK HOLDINGS INC (3151) 2,655,0004.34%19,656,797 USD
Nippon Shinyaku Co., Ltd. (4516) 519,0000.74%17,304,337 USD
T&D Holdings Inc (8795) 1,144,8800.17%16,593,925 USD
Mitsubishi Tanabe Pharma Corp (4508) 427,4000.076%7,267,980 USD
Nichi-iko Pharmaceutical Co., Ltd. (4541) 250,0000.41%5,285,368 USD
Iyo Bank Ltd (8385) 291,5660.090%3,644,881 USD
KOEI CHEMICAL COMPANY, LIMITED (4367) 910,0003.71%2,205,230 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
NOVARTIS AG
ROCHE HOLDING LTD..
PFIZER INC.
MERCK & CO., INC.
SANOFI
ACTAVIS PLC
BAYER AG
NOVO NORDISK A/S
BRISTOL-MYERS SQU..
GLAXOSMITHKLINE P..
ELI LILLY AND CO
VALEANT PHARMACEU..
ABBOTT LABORATORI..
TEVA PHARMACEUTIC..
REGENERON PHARMAC..
SHIRE PLC
TAKEDA PHARMACEUT..
MYLAN NV
CSL LIMITED
Sector Pharmaceuticals
Mitsubishi Tanabe Pharma C : Connections
Yoshitomiyakuhin Corp.
Meiji Yasuda Life Insurance Co.
The Kaiteki Institute, Inc.
Mitsubishi Tanabe Pharma Factory Ltd.
Company contact information
Mitsubishi Tanabe Pharma Corp.
3-2-10 Dosho-machi
Chuo-Ku
Osaka 541-8505

Phone : +81.6.6205.5085
Fax : +81.6.6205.5262
Web : www.mt-pharma.co.jp
© 2015 People , Fundamentals and Ownership